High-Dose Inactivated Influenza Vaccine is Associated with Cost Savings and Better Outcomes Compared to Standard-Dose Inactivated Influenza Vaccine in Canadian Seniors

D. Becker, A. Chit, C. DiazGranados, M. Maschio, E. Yau, M.F. Drummond

Research output: Contribution to journalArticlepeer-review

Search results